Data Launches
Hepatitis C Prevalence Estimates
HepVu launched interactive maps illustrating the prevalence of Hepatitis C in the United States between 2013 and 2016, stratified at the state-level by age, sex, and race.
- Published in Hepatology Communications, the data demonstrate that of the estimated 2.3 million people living with Hepatitis C infection in the U.S. during this time, the epidemic continues to disproportionately impact:
- Males
- Baby Boomer population (those born between 1945 and 1969)
- Black Americans
- Young persons in states highly affected by the opioid epidemic as a result of injection drug use
HepVu also hosted a webinar on the best practices and challenges in Hepatitis C surveillance and how to use the new interactive maps to understand Hepatitis C prevalence in the U.S.
Our Most Popular Infographics of 2020
Insights from HepVu Q&As
We continued to expand on HepVu’s series of Q&A blogs, speaking with nearly a dozen viral hepatitis and opioid experts, including four major viral hepatitis awareness days. Below are some of our most popular.
Vu Q&A: Tennessee Department of Health & Perinatal Hep C
HepVu sat down with the team at the Tennessee Department of Health that focuses on perinatal Hepatitis C to discuss their efforts to monitor infants perinatally exposed to Hepatitis C and increase perinatal screening across the state.
Learn MoreVu Q&A: Dr. Elinore McCance-Katz on Opioid Use Disorder
Elinore McCance-Katz, MD, PhD, is the first assistant secretary for mental health and substance use and leads the Substance Abuse and Mental Health Services Administration (SAMHSA). Dr. McCance-Katz discussed the development and use of medication-assisted treatment (MAT) in treating opioid use disorders.
Learn MoreVu Q&A: Lance Toma on Health Disparities in the API Community
Lance Toma, LCSW, the CEO of the San Francisco Community Health Center (SFCHC), discusses the health inequities among the Asian and Pacific Islander community.
Learn MoreVu Q&A: Kate Moraras on the Need for Universal Hepatitis B Screenings
Kate Moraras, the Deputy Director of Public Health at the Hepatitis B Foundation and the Director of Hep B United, discusses the urgent need for universal Hepatitis B screening.
Learn MoreVu Q&A: Thaddeus Pham on Hawaii’s Viral Hepatitis Elimination Strategy
Thaddeus Pham, the Viral Hepatitis Prevention Coordinator for the Hawaii Department of Health’s Harm Reduction Services Branch as well as the co-Founder and co-Director of the Hep Free Hawaii Coalition, discusses his work in helping to create Hawaii's first viral hepatitis elimination strategy plan.
Learn MoreHepVu Q&A: Dr. Su Wang on the State of Global Hepatitis Elimination During COVID-19
Dr. Su Wang, the President of the World Hepatitis Alliance and the Medical Director of the Center for Asian Health at Saint Barnabas Medical Center, discusses the need to re-prioritize viral hepatitis elimination efforts during the COVID-19 pandemic.
Learn More
